Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-117
Closed -$26K 94
2022
Q3
$26K Hold
117
0.02% 185
2022
Q2
$28K Sell
117
-20
-15% -$4.9K 0.02% 191
2022
Q1
$33K Sell
137
-61
-31% -$14K 0.02% 203
2021
Q4
$45K Buy
+198
New +$41.8K 0.04% 167
2020
Q3
$53K Sell
209
-67
-24% -$16.6K 0.06% 130
2020
Q2
$65K Hold
276
0.08% 121
2020
Q1
$56K Hold
276
0.08% 120
2019
Q4
$67K Buy
+276
New +$60.8K 0.07% 124

Other funds holding AMGN

West Bancorporation's AMGN Position: Q4 2022 in Review

West Bancorporation sold out of Amgen (AMGN) in Q4 2022, closing a stake of 117 shares — an estimated $26K sold.

West Bancorporation first reported a position in AMGN in Q4 2019 and held it in 8 quarters. The position peaked at $67K in Q4 2019. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • West Bancorporation reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • West Bancorporation sold 117 Amgen shares in Q4 2022, an estimated $26K.
  • West Bancorporation first reported a position in Amgen in Q4 2019 and held it in 8 quarters.
  • West Bancorporation's Amgen position peaked at $67K in Q4 2019.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on West Bancorporation's 13F filing for Q4 2022, filed 30 Jan 2023.